Advertisement

Topics

The Pistoia Alliance AbVance Project Reaches a Key Milestone with First Release of Antibody Structures into the Protein Data Bank

04:00 EST 9 Nov 2017 | Drug Discovery Today

The AbVance project aims to accelerate biologics drug discovery by increasing knowledge of antibody structures in the public domain

Original Article: The Pistoia Alliance AbVance Project Reaches a Key Milestone with First Release of Antibody Structures into the Protein Data Bank

NEXT ARTICLE

More From BioPortfolio on "The Pistoia Alliance AbVance Project Reaches a Key Milestone with First Release of Antibody Structures into the Protein Data Bank"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...